Triple therapy prolongs progression-free survival in Multiple Myeloma
1. Adding the proteasome inhibitor Ixazomib to lenalidomide and dexamethasone significantly increased progression-free survival compared to lenalidomide and dexamethasone ...
Tag: multiple myeloma
Targeted autologous transfusion may aid advanced refractory multiple myeloma
1. A sustained decrease of up to 12 months in serum IgA measurements was demonstrated after administration of CTL019 transfusion ...
2 Minute Medicine Rewind August 9 – August 16, 2015
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects, ...
Use of elotuzumab with conventional therapy linked to improved survival in multiple myeloma patients
1. Adding elotuzumab to the conventional lenalidomide and dezamethasone was associated with a 30% reduction in the risk of disease ...
Patient Basics: Multiple Myeloma
Originally published by Harvard Health. What Is It? Multiple myeloma is cancer of the bone marrow caused by the uncontrolled ...
2 Minute Medicine Rewind September 1 – September 8, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Use ...
FIRST trial: Lenalidomide with dexamethasone beats standard chemotherapy for multiple myeloma
1. Progression-free survival was improved by about 3 months with continuous lenalidomide-dexamethasone compared to standard melphalan-prednisone-thalidomide. 2. Overall survival was ...
Continued post-transplant response predicts improved prognosis in multiple myeloma
Image: PD RANKL protein structure 1. Continued monoclonal protein response to autologous stem cell transplantation (ASCT) is associated with improved ...
2 Minute Medicine Rewind July 29 – August 4, 2013
In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week. ...
Phase III trial shows survival benefit for early multiple myeloma
Image: CC/Osaro 1. Treatment with lenalidomide and dexamethasone significantly delayed disease progression in patients with smoldering multiple myeloma who were ...
Popular Reports
-
Ultrasound features associated with shoulder complaints
-
Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder
-
Logistical barriers may impact access to contraceptive use amongst females with opioid use disorder
-
#VisualAbstract: Adequate antibody response to mRNA-1273 COVID-19 vaccine occurs in patients with cancer
-
Geriatric assessment and management may reduce adverse events in older cancer patients
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.